Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
The antidepressant mirtazapine improves survival in patients with primary biliary cholangitis — Abdel Aziz Shaheen (2018) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
The antidepressant mirtazapine improves survival in patients with primary biliary cholangitis
Shared by
Scott Burton Patten
The antidepressant mirtazapine improves survival in patients with primary biliary cholangitis
Article
2018
en
Authors
+2 more
AS
Abdel Aziz Shaheen
GK
Gulcan Kaplan
WA
Wagdi Almishri
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2018
The impact of depression and antidepressant usage on primary biliary cholangitis clinical outcomes
Abdel Aziz Shaheen
,
Gilaad G. Kaplan
,
Wagdi Almishri
,
Isabelle A. Vallerand
,
Alexandra Frolkis
,
Scott Burton Patten
,
Mark G. Swain
Article
2021
Beneficial autoimmunity links primary biliary cholangitis to the avoidance of cholangiocarcinoma
Jonathan Pol
,
Juliette Paillet
,
Céleste Plantureux
,
Guido Guido Kroemer
Article
2025
[Predictive value of neutrophil/lymphocyte ratio in the prognosis of primary biliary cholangitis].
Huanling Zhu
,
Mao Zheng
,
Li Wen
,
Yanqi Huang
,
L L Zhang
,
Winnie Yang
,
Min Zhou
,
Jinhui Yang
Dataset
Faculty Opinions recommendation of norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis.
Ralf Weiskirchen
Article
2020
Ursodeoxycholic acid response in primary biliary cholangitis is associated with a significant reduction in decompensation and mortality in compensated cirrhosis
Binu V. John
,
Nidah S. Khakoo
,
Gabriella Aitcheson
,
Cynthia Levy
,
David Goldberg
,
Kalyan Ram Bhamidimarri
,
María Hernández
,
Bassam Dahman
,
Yangyang Deng
,
Paul Martin
,
Tamar H. Taddei
,
David Kaplan
Discussion(0)
No comments yet. Be the first to comment.